561 results match your criteria: "National Institute for Infectious Diseases L[Affiliation]"

Defective peripheral B cell selection in common variable immune deficiency patients with autoimmune manifestations.

Cell Rep

May 2023

Institute of Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology, and Immunology, Medical University of Vienna, Vienna, Austria; Department of Rheumatology and Inflammation Research, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; B Cell Pathophysiology Unit, Immunology Research Area, Ospedale Pediatrico Bambino Gesù IRCCS, Rome, Italy. Electronic address:

Common variable immune deficiency (CVID) is a heterogeneous disorder characterized by recurrent infections, low levels of serum immunoglobulins, and impaired vaccine responses. Autoimmune manifestations are common, but B cell central and peripheral selection mechanisms in CVID are incompletely understood. Here, we find that receptor editing, a measure of central tolerance, is increased in transitional B cells from CVID patients and that these cells have a higher immunoglobulin κ:λ ratio in CVID patients with autoimmune manifestations than in those with infection only.

View Article and Find Full Text PDF
Article Synopsis
  • The epidermis serves as a crucial barrier to prevent water loss, relying on lipids like ceramides, cholesterol, and very long chain fatty acids for proper function.
  • Alterations in these lipids can lead to skin disorders such as psoriasis and atopic dermatitis, with a specific genetic mutation linked to seborrhea-like dermatitis.
  • The study highlights the transcription factor ZFP750 as a key regulator in maintaining epidermal lipid balance and its role in the biosynthesis of ceramides, enhancing our understanding of skin disease mechanisms.
View Article and Find Full Text PDF

Apoptosis is a form of regulated cell death (RCD) that involves proteases of the caspase family. Pharmacological and genetic strategies that experimentally inhibit or delay apoptosis in mammalian systems have elucidated the key contribution of this process not only to (post-)embryonic development and adult tissue homeostasis, but also to the etiology of multiple human disorders. Consistent with this notion, while defects in the molecular machinery for apoptotic cell death impair organismal development and promote oncogenesis, the unwarranted activation of apoptosis promotes cell loss and tissue damage in the context of various neurological, cardiovascular, renal, hepatic, infectious, neoplastic and inflammatory conditions.

View Article and Find Full Text PDF

Objectives: Bezlotoxumab (BEZ) is a promising tool for preventing the recurrence of Clostridioides difficile infection (rCDI). The aim of the study was to emulate, in a real-world setting, the MODIFY trials in a cohort of participants with multiple risk factors for rCDI treated with BEZ in addition to the standard of care (SoC) versus SoC alone.

Methods: A multicenter cohort study was conducted including 442 patients with Clostridioides difficile infection from 2018 to 2022, collected from 18 Italian centers.

View Article and Find Full Text PDF

Chronic kidney disease (CKD) incidence is growing worldwide, with a significant percentage of CKD patients reaching end-stage renal disease (ESRD) and requiring kidney replacement therapies (KRT). Peritoneal dialysis (PD) is a convenient KRT presenting benefices as home therapy. In PD patients, the peritoneum is chronically exposed to PD fluids containing supraphysiologic concentrations of glucose or other osmotic agents, leading to the activation of cellular and molecular processes of damage, including inflammation and fibrosis.

View Article and Find Full Text PDF

Background: Immunosuppression after kidney transplantation is mainly guided via plasma tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The plasma load of the non-pathogenic and highly prevalent torque teno virus (TTV) is associated with the immunosuppression of its host. Non-interventional studies suggest the use of TTV load to predict allograft rejection and infection.

View Article and Find Full Text PDF
Article Synopsis
  • Weaker immune responses were observed in liver transplant recipients after receiving just two doses of anti-SARS-CoV2 vaccination, prompting a study on the effects of a third dose.
  • In a study involving 122 liver transplant recipients, significant improvements in both humoral (antibodies) and cell-mediated (T-cell activity) immune responses were noted after the third vaccine dose, with 86.4% of previously non-responding patients showing a positive response.
  • Factors such as shorter time since transplantation were linked to reduced immune responses, while the presence of mycophenolate mofetil did not negatively impact the response rates; 60% of patients maintained protective antibodies against the Omicron variant 12 weeks post-third dose
View Article and Find Full Text PDF

To compare the detection of the SARS-CoV-2 Omicron variant in nasopharyngeal-swab (NPS) and oral saliva samples. 255 samples were obtained from 85 Omicron-infected patients. SARS-CoV-2 load was measured in the NPS and saliva samples by using Simplexa™ COVID-19 direct and Alinity m SARS-CoV-2 AMP assays.

View Article and Find Full Text PDF
Article Synopsis
  • Recent advancements in nanotechnology are improving cancer treatment by enhancing drug delivery methods and reducing side effects.
  • Autophagy plays a crucial role in cancer cell behavior but is often disrupted in tumors, making effective therapeutic approaches targeting it limited.
  • Combining nanoparticles with autophagy modulators may increase the effectiveness and safety of cancer treatments, as this review explores existing research and future potential in this area.
View Article and Find Full Text PDF

Variation in Post-Transplant Cancer Incidence among Italian Kidney Transplant Recipients over a 25-Year Period.

Cancers (Basel)

February 2023

Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy.

This cohort study examined 25-year variations in cancer incidence among 11,418 Italian recipients of kidney transplantation (KT) from 17 Italian centers. Cancer incidence was examined over three periods (1997-2004; 2005-2012; and 2013-2021) by internal (Incidence rate ratio-IRR) and external (standardized incidence ratios-SIR) comparisons. Poisson regression was used to assess trends.

View Article and Find Full Text PDF

In this Special Issue, many original contributions concerning serological methods for SARS-CoV-2 were collected, some of them with implications about therapeutics [...

View Article and Find Full Text PDF
Article Synopsis
  • COVID-19 cases surged in China by the end of 2022, prompting some countries to enhance testing for travelers.
  • In Italy, 556 passengers arriving from two Chinese provinces were screened in late December 2022, with 126 (22.7%) testing positive for SARS-CoV-2.
  • Whole genome sequencing of 61 positive samples showed Omicron variants, specifically sub-lineages BA.5.2.48, BF.7.14, and BQ.1.1, consistent with recent data from China.
View Article and Find Full Text PDF

Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study).

Int J Antimicrob Agents

March 2023

Infectious Diseases Unit, Department of Integrated Management of Infectious Risk, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Article Synopsis
  • Infections of cardiovascular implantable electronic devices (CIED) are primarily caused by Gram-positive bacteria, but this study focuses on the less common Gram-negative bacteria (GNB) infections, aiming to understand their risk factors, clinical features, and outcomes.
  • The study analyzed data from 236 patients across 17 European centers, comparing 59 patients with GNB-CIED infections to controls with Gram-positive infections and those without infections, finding no major differences in clinical presentation but notable trends in diagnostic imaging.
  • Key risk factors for GNB infections included obesity, a high comorbidity index, specific pacemaker settings, and the right subclavian vein site for device implantation; these infections were also linked to higher mortality rates, suggesting
View Article and Find Full Text PDF

YES-associated protein (YAP) is a transcriptional cofactor with a key role in the regulation of several physio-pathological cellular processes, by integrating multiple cell autonomous and microenvironmental cues. YAP is the main downstream effector of the Hippo pathway, a tumor-suppressive signaling able to transduce several extracellular signals. The Hippo pathway acts restraining YAP activity, since its activation induces YAP phosphorylation and cytoplasmic sequestration.

View Article and Find Full Text PDF

Diagnostic services for tuberculosis (TB) are not sufficiently accessible in low-resource settings, where most cases occur, which was aggravated by the COVID-19 pandemic. Early diagnosis of pulmonary TB can reduce transmission. Current TB-diagnostics rely on detection of in sputum requiring costly, time-consuming methods, and trained staff.

View Article and Find Full Text PDF

Aim: To evaluate the role of lung ultrasound (LUS) in recognizing lung abnormalities in pregnant women affected by COVID-19 pneumonia.

Materials And Methods: An observational study analyzing LUS patterns in 60 consecutively enrolled pregnant women affected by COVID-19 infection was performed. LUS was performed by using a standardized protocol by Soldati et al.

View Article and Find Full Text PDF

The issue of bacterial infections in COVID-19 patients has received increasing attention among scientists. Antibiotics were widely prescribed during the early phase of the pandemic. We performed a literature review to assess the reasons, evidence and practices on the use of antibiotics in COVID-19 in- and outpatients.

View Article and Find Full Text PDF

European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).

J Hosp Infect

January 2023

Healthcare Associated Infections Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK; European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Study Group for Clostridioides Difficile (ESGCD); Department of Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Background: Awareness and compliance with international guidelines for diagnosis and clinical management of Clostridioides difficile infection (CDI) are unknown.

Aim: To compare the awareness and compliance with the recommended strategies for diagnosis and clinical management of CDI across Europe in 2018-2019.

Methods: Hospital sites and their associated community practices across 12 European countries completed an online survey in 2018-2019, to report on their practices in terms of surveillance, prevention, diagnosis, and treatment of CDI.

View Article and Find Full Text PDF

The measure of torquetenovirus (TTV) viremia is widely recognized as an optimal biomarker of an individual immune status. In the context of COVID-19, the predictive role of TTV load with regard to vaccine response has also been demonstrated, suggesting other intriguing applications for this widespread anellovirus.

View Article and Find Full Text PDF
Article Synopsis
  • In a study on peritoneal fibrosis, the HDAC inhibitor MS-275 was found to promote the expression of miR-769-5p, which can reverse mesothelial to mesenchymal transition (MMT) and reduce the invasive properties of mesothelial cells.
  • The transcription factor Wilms' tumor 1 (WT1) was identified as a key regulator that enhances miR-769-5p expression after HDAC1 inhibition, indicating a complex interplay in cellular communication that could impact treatment strategies for fibrosis. *
View Article and Find Full Text PDF

The wild-type SARS-CoV-2 Spike-based vaccines authorized so far have reduced COVID-19 severity, but periodic boosts are required to counteract the decline in immunity. An accelerated rate of immune escape to vaccine-elicited immunity has been associated with Spike protein antigenic shifts, as seen in the Omicron variant of concern and its sublineages, demanding the development of Omicron Spike-based vaccines. Herein, we review the evidence in animal models and topline results from ongoing clinical trials with such updated vaccines, discussing the pros and cons for their deployment.

View Article and Find Full Text PDF

Bezlotoxumab in Patients with a Primary Infection: A Literature Review.

Antibiotics (Basel)

October 2022

Infectious Disease Unit, ARNAS Civico-Di Cristina, Piazza Leotta, 5, 90100 Palermo, Italy.

Background: Nowadays, one of the main issues in the management of infection (CDI) is the high rate of recurrences (rCDI), causing increased mortality and higher health care costs.

Objectives: To assess the available evidence on the use of bezlotoxumab for the prevention of rCDI during a first CDI episode.

Methods: Published articles on bezlotoxumab during a primary CDI episode were identified through computerized literature searches with the search terms [(bezlotoxumab) AND (CDI) OR ( infection)] using PubMed and by reviewing the references of retrieved articles.

View Article and Find Full Text PDF

Importance: Despite people with impaired immune competence due to an underlying disease or ongoing therapy, hereinafter frail patients, are (likely to be) the first to be vaccinated, they were usually excluded from clinical trials.

Objective: To report adverse reactions of frail patients after receipt of the third dose (booster) administered after completion of a two-dose mRNA vaccination and to compare with those reported after the receipt of the first two doses.

Design: A multicenter, observational, prospective study aimed at evaluating both the safety profile and the immune response of Pfizer-BioNTech or Moderna vaccines in frail patients.

View Article and Find Full Text PDF